Summary

Global Gastric Cancer Drugs Market 2024-2028
The gastric cancer drugs market is forecasted to grow by USD 19489.6 mn during 2023-2028, accelerating AT a CAGR of 18.52% during the forecast period. The report on the gastric cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing awareness campaigns for gastric cancer, growing geriatric population, and increasing prevalence of gastric cancer .
Technavio's gastric cancer drugs market is segmented as below:
By Route Of Administration
• Injectable
• Oral
By Distribution Channel
• Offline
• Online
By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the increase in number of drug approvals and drug launches as one of the prime reasons driving the gastric cancer drugs market growth during the next few years. Also, strong pipeline of gastric cancer drugs and increasing R and D by vendors will lead to sizable demand in the market.
The report on the gastric cancer drugs market covers the following areas:
• Gastric cancer drugs market sizing
• Gastric cancer drugs market forecast
• Gastric cancer drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastric cancer drugs market vendors that include Abbott Laboratories, AbbVie Inc., AROG Pharmaceuticals INC., AstraZeneca PLC, Bayer AG, Biocon Ltd., Blueprint Medicines Corp., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Celltrion Co. Ltd., DR Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Merck KGaA, Novartis AG, Otsuka Holdings Co. Ltd., Samsung Biologics Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Zydus Lifesciences Ltd.. Also, the gastric CANCER drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - [https://www.technavio.com/report/gastric-cancer-drugs-market-analysis](https://www.technavio.com/report/gastric-CANCER-drugs-market-analysis)
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Executive Summary - Chart on Market Overview
o Executive Summary - Data Table on Market Overview
o Executive Summary - Chart on Global Market Characteristics
o Executive Summary - Chart on Market by Geography
o Executive Summary - Chart on Market Segmentation by Route of Administration
o Executive Summary - Chart on Market Segmentation by Distribution Channel
o Executive Summary - Chart on Incremental Growth
o Executive Summary - Data Table on Incremental Growth
o Executive Summary - Chart on Company Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Parent Market
o Data Table on - Parent Market
o 2.2 Market characteristics
o Market characteristics analysis
o 2.3 Value chain analysis
o Value Chain Analysis
• 3 Market Sizing
o 3.1 Market definition
o Offerings of companies included in the market definition
o 3.2 Market segment analysis
o Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Chart on Global - Market size and forecast 2023-2028 ($ million)
o Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global Gastric Cancer Drugs Market 2018 - 2022
o Historic Market Size - Data Table on Global Gastric Cancer Drugs Market 2018 - 2022 ($ million)
o 4.2 Route of Administration segment analysis 2018 - 2022
o Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
o 4.3 Distribution Channel segment analysis 2018 - 2022
o Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
o 4.4 Geography segment analysis 2018 - 2022
o Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country segment analysis 2018 - 2022
o Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Route of Administration
o 6.1 Market segments
o Chart on Route of Administration - Market share 2023-2028 (%)
o Data Table on Route of Administration - Market share 2023-2028 (%)
o 6.2 Comparison by Route of Administration
o Chart on Comparison by Route of Administration
o Data Table on Comparison by Route of Administration
o 6.3 Injectable - Market size and forecast 2023-2028
o Chart on Injectable - Market size and forecast 2023-2028 ($ million)
o Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
o Chart on Injectable - Year-over-year growth 2023-2028 (%)
o Data Table on Injectable - Year-over-year growth 2023-2028 (%)
o 6.4 Oral - Market size and forecast 2023-2028
o Chart on Oral - Market size and forecast 2023-2028 ($ million)
o Data Table on Oral - Market size and forecast 2023-2028 ($ million)
o Chart on Oral - Year-over-year growth 2023-2028 (%)
o Data Table on Oral - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Route of Administration
o Market opportunity by Route of Administration ($ million)
o Data Table on Market opportunity by Route of Administration ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Chart on Distribution Channel - Market share 2023-2028 (%)
o Data Table on Distribution Channel - Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Chart on Comparison by Distribution Channel
o Data Table on Comparison by Distribution Channel
o 7.3 Offline - Market size and forecast 2023-2028
o Chart on Offline - Market size and forecast 2023-2028 ($ million)
o Data Table on Offline - Market size and forecast 2023-2028 ($ million)
o Chart on Offline - Year-over-year growth 2023-2028 (%)
o Data Table on Offline - Year-over-year growth 2023-2028 (%)
o 7.4 Online - Market size and forecast 2023-2028
o Chart on Online - Market size and forecast 2023-2028 ($ million)
o Data Table on Online - Market size and forecast 2023-2028 ($ million)
o Chart on Online - Year-over-year growth 2023-2028 (%)
o Data Table on Online - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Distribution Channel
o Market opportunity by Distribution Channel ($ million)
o Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Chart on Market share by geography 2023-2028 (%)
o Data Table on Market share by geography 2023-2028 (%)
o 9.2 Geographic comparison
o Chart on Geographic comparison
o Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Chart on North America - Market size and forecast 2023-2028 ($ million)
o Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Chart on North America - Year-over-year growth 2023-2028 (%)
o Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Chart on Europe - Year-over-year growth 2023-2028 (%)
o Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Chart on Asia - Year-over-year growth 2023-2028 (%)
o Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Chart on US - Market size and forecast 2023-2028 ($ million)
o Data Table on US - Market size and forecast 2023-2028 ($ million)
o Chart on US - Year-over-year growth 2023-2028 (%)
o Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Chart on Germany - Year-over-year growth 2023-2028 (%)
o Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 UK - Market size and forecast 2023-2028
o Chart on UK - Market size and forecast 2023-2028 ($ million)
o Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Chart on UK - Year-over-year growth 2023-2028 (%)
o Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.10 China - Market size and forecast 2023-2028
o Chart on China - Market size and forecast 2023-2028 ($ million)
o Data Table on China - Market size and forecast 2023-2028 ($ million)
o Chart on China - Year-over-year growth 2023-2028 (%)
o Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.11 Canada - Market size and forecast 2023-2028
o Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Chart on Canada - Year-over-year growth 2023-2028 (%)
o Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity by geography
o Market opportunity by geography ($ million)
o Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Opportunity/Restraints
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Impact of drivers and challenges in 2023 and 2028
o 10.4 Market opportunities/restraints
• 11 Competitive Landscape
o 11.1 Overview
o 11.2 Competitive Landscape
o Overview on criticality of inputs and factors of differentiation
o 11.3 Landscape disruption
o Overview on factors of disruption
o 11.4 Industry risks
o Impact of key risks on business
• 12 Competitive Analysis
o 12.1 Companies profiled
o Companies covered
o 12.2 Market positioning of companies
o Matrix on companies position and classification
o 12.3 Abbott Laboratories
o Abbott Laboratories - Overview
o Abbott Laboratories - Business segments
o Abbott Laboratories - Key news
o Abbott Laboratories - Key offerings
o Abbott Laboratories - Segment focus
o 12.4 AROG Pharmaceuticals INC.
o AROG Pharmaceuticals INC. - Overview
o AROG Pharmaceuticals INC. - Product / Service
o AROG Pharmaceuticals INC. - Key offerings
o 12.5 AstraZeneca Plc
o AstraZeneca Plc - Overview
o AstraZeneca Plc - Product / Service
o AstraZeneca Plc - Key news
o AstraZeneca Plc - Key offerings
o 12.6 Bayer AG
o Bayer AG - Overview
o Bayer AG - Business segments
o Bayer AG - Key news
o Bayer AG - Key offerings
o Bayer AG - Segment focus
o 12.7 Biocon Ltd.
o Biocon Ltd. - Overview
o Biocon Ltd. - Business segments
o Biocon Ltd. - Key offerings
o Biocon Ltd. - Segment focus
o 12.8 Boehringer Ingelheim International GmbH
o Boehringer Ingelheim International GmbH - Overview
o Boehringer Ingelheim International GmbH - Product / Service
o Boehringer Ingelheim International GmbH - Key news
o Boehringer Ingelheim International GmbH - Key offerings
o 12.9 Bristol Myers Squibb Co.
o Bristol Myers Squibb Co. - Overview
o Bristol Myers Squibb Co. - Product / Service
o Bristol Myers Squibb Co. - Key news
o Bristol Myers Squibb Co. - Key offerings
o 12.10 Celltrion Co. Ltd.
o Celltrion Co. Ltd. - Overview
o Celltrion Co. Ltd. - Product / Service
o Celltrion Co. Ltd. - Key offerings
o 12.11 Dr Reddys Laboratories Ltd.
o Dr Reddys Laboratories Ltd. - Overview
o Dr Reddys Laboratories Ltd. - Business segments
o Dr Reddys Laboratories Ltd. - Key news
o Dr Reddys Laboratories Ltd. - Key offerings
o Dr Reddys Laboratories Ltd. - Segment focus
o 12.12 Eisai Co. Ltd.
o Eisai Co. Ltd. - Overview
o Eisai Co. Ltd. - Business segments
o Eisai Co. Ltd. - Key offerings
o Eisai Co. Ltd. - Segment focus
o 12.13 Eli Lilly and Co.
o Eli Lilly and Co. - Overview
o Eli Lilly and Co. - Product / Service
o Eli Lilly and Co. - Key news
o Eli Lilly and Co. - Key offerings
o 12.14 F. Hoffmann La Roche Ltd.
o F. Hoffmann La Roche Ltd. - Overview
o F. Hoffmann La Roche Ltd. - Business segments
o F. Hoffmann La Roche Ltd. - Key news
o F. Hoffmann La Roche Ltd. - Key offerings
o F. Hoffmann La Roche Ltd. - Segment focus
o 12.15 Merck KGaA
o Merck KGaA - Overview
o Merck KGaA - Business segments
o Merck KGaA - Key news
o Merck KGaA - Key offerings
o Merck KGaA - Segment focus
o 12.16 Novartis AG
o Novartis AG - Overview
o Novartis AG - Business segments
o Novartis AG - Key news
o Novartis AG - Key offerings
o Novartis AG - Segment focus
o 12.17 Samsung Biologics Co. Ltd.
o Samsung Biologics Co. Ltd. - Overview
o Samsung Biologics Co. Ltd. - Product / Service
o Samsung Biologics Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Inclusions checklist
o Exclusions checklist
o 13.3 Currency conversion rates for US$
o Currency conversion rates for US$
o 13.4 Research methodology
o Research methodology
o 13.5 Data procurement
o Information sources
o 13.6 Data validation
o Data validation
o 13.7 Validation techniques employed for market sizing
o Validation techniques employed for market sizing
o 13.8 Data synthesis
o Data synthesis
o 360 degree market analysis
o 360 degree market analysis
o 13.10 List of abbreviations
o List of abbreviations